ASTRO/JASTRO Joint Session: Advances in Liver Cancer Radiation Therapy
The role of this activity reviews growing indications for radiation therapy for liver cancer, educates providers on radiation therapy options (SBRT, particle therapy) and the potential impact of hepatic reserve capacity on decision making, explores challenges and opportunities for clinical trials
Category
  • Gastrointestinal
  • SBRT
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Advances in Breast Cancer Management: Early-Stage Disease, Post-Neoadjuvant Radiation Therapy and IMRT for Breast Cancer Treatment in a Community Setting
There are multiple new developments in the treatment of breast cancer patients with radiation therapy, as well as ongoing developments in the use of breast IMRT. Practicing clinicians need to stay informed to improve outcomes among breast cancer patients.  
Category
  • Breast
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Management of Unfavorable Intermediate-Risk Prostate Cancer: Role of SBRT, Brachytherapy and Androgen Deprivation
Unfavorable intermediate-risk prostate cancer is commonly encountered in clinical practice but there is relatively little data focusing on treatment outcomes specific and limited to this patient cohort, with most clinical trials grouping these patients with favorable intermediate-risk disease or
Category
  • Brachytherapy
  • Genitourinary
  • SBRT
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Management of Small Cell Neuroendocrine Tumors of the Genitourinary Tract
Molecular diagnostics are rapidly evolving, leading to increased identification of previously 'rare' clinical entities.
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Emerging Role of CT and MR-Guided Online Adaptive Radiotherapy for Upper GI Malignancies
Online adaptive radiotherapy (ART) is a current and emerging technology and approach that leverages CT and MR images obtained on the treatment delivery platform to personalized daily RT fractions to account for organ and tumor motion, deformation, and positioning with the potential of improving o
Category
  • Adaptive RT
  • Gastrointestinal
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Implementation of a Prostate SBRT Program in the Community Setting
Conventionally fractionated external beam radiation therapy (EBRT) has a long-standing track record of safety and excellent treatment outcomes in the management of all prostate cancer risk groups.
Category
  • Genitourinary
  • SBRT
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Fine ART: Ever Evolving Online Adaptive Radiotherapy Technologies and Clinical Innovations
In the field of Adaptive Radiotherapy (ART), there are significant challenges in ensuring patient safety and treatment efficacy with the proper implementation of ART workflows and ART tools, effectively evaluating and implementing current clinical research, navigating the technical advancements a
Category
  • Adaptive RT
Format
  • Sessions onDemand
Credits
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Certificate of Attendance
Cost $149.00
Prevention and Management of Toxicity in Organs at Risk (OAR) in a Community Setting
This activity focuses entirely on issues related to the Organs at Risk (OAR) in the setting of thoracic radiation. Discussion centers on protecting the OARs and managing acute and late toxicities. Each speaker focuses on a different clinical situation.
Category
  • SBRT
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Integration of HPV ctDNA Testing into Clinical Practice for HPV+ OPSCC – Ready for Prime Time?
The use of HPV ctDNA in the clinical management of patients with HPV-associated oropharyngeal squamous cell carcinoma is rapidly increasing; however, questions remain regarding its utility and validity in various clinical settings.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
A Case-Based Interactive Discussion of the ASTRO Clinical Practice Guideline for HPV-Positive Oropharyngeal Squamous Cell Carcinoma
This case-based activity is designed to provide learners with practical guidance on management of HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) and highlight areas of uncertainty where there may be a range of acceptable treatment approaches.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00

Pages